Saturday 17 October 2026
Export QTI’s income statement to Excel — free account
QT Imaging Holdings, Inc.
QTI Healthcare Medical Devices
QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024. In the quarter to June 2026, revenue grew 103.2%, EPS fell 78.6%, free cash flow fell 236.3% and total debt rose 286.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.41
0.03
+1.26%
Follow QTI
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 147.00 | 147.15 | 153.00 | 5.25 | 3.11 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | 149.40 | 155.10 | 177.00 | 216.00 | 46.05 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | 3 | 3 | 3 | 21 | 32 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.23 | 0.59 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 0 | 5 | 19 | ||||
| Gross margin, % | — | — | — | — | — | — | — | (234.16) | 54.11 | 45.36 | |||||
| EBT | — | — | — | — | — | (1) | (2) | (6) | (9) | (21) | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | (15,092.57) | (184.48) | (111.41) | |||||
| Net income | — | — | — | — | — | (1) | (3) | (6) | (9) | (21) | |||||
| Depreciation | — | — | — | — | — | — | 0 | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.73 | 1.81 | ||||
| Earnings | — | — | — | — | — | (0.41) | (0.35) | (1.92) | (2.13) | (2.01) | |||||
| Cash flow | — | — | — | — | — | (0.50) | (0.58) | (0.83) | (1.51) | (0.86) | |||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.01) | (0.01) | |||||
| Free cash flow | — | — | — | — | — | (0.50) | (0.58) | (0.84) | (1.52) | (0.87) | |||||
| Book value | — | — | — | — | — | (3.27) | (6.00) | (1.67) | (1.43) | 0.62 | |||||
| Shares, m | — | — | — | — | — | 3 | 2 | 3 | 7 | 10 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 12,942.56 | 9.99 | 3.38 | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 9.92 | |||||
| EV/Sales | — | — | — | — | — | — | — | 13,121.68 | 11.56 | 3.07 | |||||
| EV/FCF | — | — | — | — | — | — | — | (199.48) | (5.58) | (6.35) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (1) | (1) | (3) | (10) | (9) | ||||
| Capex | — | — | — | — | — | — | — | 0 | 0 | 0 | |||||
| Free cash flow | — | — | — | — | — | (1) | (1) | (3) | (10) | (9) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 1 | (4) | (3) | (5) | 14 | ||||
| Total debt | — | — | — | — | — | 0 | 2 | 7 | 9 | 5 | |||||
| Net debt | — | — | — | — | — | 0 | 2 | 7 | 8 | (6) | |||||
| Shareholders’ equity | — | — | — | — | — | (9) | (13) | (5) | (10) | 6 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (2.84) | (25.07) | (221.53) | (144.86) | ||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | (161.15) | 0.00 | (486.51) | |||||
| ROE | — | — | — | — | — | 0.00 | 35.62 | 66.32 | 190.85 | 1,363.27 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
QT Imaging Holdings, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SNWV Sanuwave Health Inc. | $44.5M | 3.0× | — (loss-making) | −3.13% (below 0%: shrinking) | n/m | +86.75% (above 0%: growing) | 76.23% | (2.88%) | Compare |
| XTNT Xtant Medical Holdings, Inc. | $42.5M | — (loss-making) | — (loss-making) | −34.96% (below 0%: shrinking) | n/m | −881.96% (below 0%: shrinking) | 57.88% | (39.81%) | Compare |
| RPID Rapid Micro Biosystems, Inc. | $42.4M | — (loss-making) | — (loss-making) | +10.91% (above 0%: growing) | n/m | −23.97% (below 0%: shrinking) | 15.05% | (152.99%) | Compare |
| NNOX Nano-X Imaging Ltd. | $38.6M | — (loss-making) | — (loss-making) | +36.71% (above 0%: growing) | n/m | −21.37% (below 0%: shrinking) | (1,050.87%) | (1,334.91%) | Compare |
| CVRX CVRx, Inc. | $37.0M | — (loss-making) | — (loss-making) | +15.57% (above 0%: growing) | n/m | −11.18% (below 0%: shrinking) | 87.39% | (82.92%) | Compare |
| ELUT Elutia Inc. | $34.9M | 0.6× | — (loss-making) | −11.65% (below 0%: shrinking) | n/m | −2.52% (below 0%: shrinking) | 59.62% | (327.85%) | Compare |
| QTI QT Imaging Holdings, Inc. | $34.8M | — (loss-making) | — (loss-making) | +103.20% (above 0%: growing) | n/m | −236.31% (below 0%: shrinking) | 41.16% | (25.07%) | |
| NSYS Nortech Systems Incorporated | $29.5M | 27.9× | 17.5× | +9.34% (above 0%: growing) | −8.33% (below 0%: shrinking) | −1,567.16% (below 0%: shrinking) | 17.00% | 1.86% | Compare |
| ITOC iTonic Holdings Ltd. | $29.3M | — | — | — | — | — | — | — | Compare |
| Median of peers | $37.8M | 3.0× | — | +9.34% | — | −21.37% | 57.88% | (82.92%) |
QT Imaging Holdings, Inc. (QTI) key facts
- Strength: QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024.
- QT Imaging Holdings, Inc. (QTI) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, QTI traded at $2.41, a market capitalization of $34.8 million.
- Return on equity was 1,363.3% and debt-to-equity 6.81.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 0.02 (distress zone) for fiscal 2025.